# The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia

Study · id `cardio:ct-nct02407548` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02407548](<https://clinicaltrials.gov/study/NCT02407548>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02407548

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT02407548. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (actual); primary completion 2017-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT02407548, source copy `cardio:ctgov-nct02407548-2017-06-22`, retrieved 2026-10-31)
- Started: 2015-07 (actual) (ClinicalTrials.gov record NCT02407548, source copy `cardio:ctgov-nct02407548-2017-06-22`, retrieved 2026-10-31)
- Primary completion: 2017-04 (actual) (ClinicalTrials.gov record NCT02407548, source copy `cardio:ctgov-nct02407548-2017-06-22`, retrieved 2026-10-31)
- Completion: 2017-04 (actual) (ClinicalTrials.gov record NCT02407548, source copy `cardio:ctgov-nct02407548-2017-06-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02407548, source copy `cardio:ctgov-nct02407548-2017-06-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02407548-2017-06-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia
- Acronym: TEDSCD
- Condition: Dyslipidemia
- Intervention (Dietary supplement): coenzyme Q10 vitamin E softgel
- Intervention (Dietary supplement): coenzyme Q10 softgel
- Intervention (Dietary supplement): placebo softgel
- Lead sponsor: Sun Yat-sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Sun Yat-sen University (`cardio:org-sun-yat-sen-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals (`cardio:pubmed-29454678`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: af572ba1fb8050050c1ad55bf6c24143e2643a884819c368f76cde3de2949521
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
